無線膠囊內窺鏡（CE）是一種用於檢查整個胃腸道，尤其是小腸的無創技術。它極大地改善了許多小腸疾病的診斷和管理方式，如不明原因的消化道出血，克羅恩病，小腸腫瘤，息肉綜合征等。儘管膠囊內窺鏡有很好的臨床表現，但它仍然有一定的局限性。主要問題是每次檢查產生約50,000 幅低質量的圖像，對於醫生來說，評估如此大量的圖像是一項非常耗時、耗力的工作。 / 到目前為止，對於膠囊內窺鏡的分析和評估，學者們都把膠囊內窺鏡圖像視為單獨的，獨立的觀測對象。事實並非如此，因為圖像之間往往有顯著的重疊。特別是當膠囊內窺鏡在被小腸蠕動緩緩推動時，它可以捕捉同一病灶的多個視圖。我們的研究目的是使用所有可用的資訊，包括多幅圖像，研究對於膠囊內窺鏡的電腦輔助診斷（CAD）系統。 / 在這篇論文中，我們提出了一個嵌入分類器的多類隱馬爾可夫模型（HMM）的方案，它可以融合多幅相鄰圖像的時間資訊。由於膠囊內窺鏡圖像的品質比較低，我們首先進行預處理，以加強膠囊內窺鏡圖像，增加其對比度，消除噪聲。我們調查研究了多種圖像增強的方法，並調整了它們的參數使其適用於膠囊內窺鏡圖像。 / 對於基於單幅圖像的有監督的分類，AdaBoost 作為一個集成分類器來融合多個分類器，即本論文中的支持向量機（SVM），k-近鄰（k-NN），貝葉斯分類。在分類之前，我們提取和融合了顏色，邊緣和紋理特徵。 / 對於無線膠囊內窺鏡的視頻摘要，我們提出了有監督和無監督的兩類方法。對於有監督方法，我們提出了一個基於隱馬爾可夫模型的，靈活的，可擴展的框架，用於整合膠囊內窺鏡中連續圖像的時間資訊。它可以擴展到多類別，多特徵，多狀態。我們還提出了聯合隱馬爾可夫模型和並行隱馬爾可夫（PHMM）模型對系統進行改進，它們可以被看作是決策級的資訊融合。聯合隱馬爾可夫模型通過多層次的隱馬爾可夫模型，結合不同的資訊來源，對膠囊內窺鏡視頻進行分類和視頻摘要。 並行隱馬爾可夫模型採用貝葉斯推理，在決策時融合多個不同來源的資訊。對於無監督的方法，我們首先提出了一種基於顏色的特徵提取方法。在反色顏色空間中對亮度不變的色度不變矩用來表示膠囊內窺鏡圖像的顏色特徵。接著，我們又提出了一種基於輪廓元（Contourlet）變換的局部二元模式（LBP）作為紋理特徵。在特徵空間中，我們測量了相鄰圖像的距離，並把它視為一個位於二維平面上的開放輪廓上的點。 然後，我們採用一個無參數的關鍵點檢測方法檢測在視頻片段上的突變關鍵點。基於這些突變關鍵點，我們對膠囊內窺鏡視頻進行分割。最後，在每段被分割的視頻片段上，我們通過提取有代表性的關鍵幀來實現膠囊內窺鏡視頻摘要。我們分別用模擬和真實的病人數據進行實驗，對提出的方法進行驗證，結果表明了我們所提出的方案的有效性。它在實現自動評估膠囊內窺鏡圖像上具有很大的潛力。 / Wireless Capsule Endoscopy (CE) is a non-invasive technology to inspect the whole gastrointestinal (GI) tract, especially the small intestine. It has dramatically changed the way of diagnosis and management of many diseases of the small intestine, such as obscure gastrointestinal bleeding, Crohn’s disease, small bowel tumors, polyposis syndromes, etc. Despite its promising clinical findings, it still has some limitations. The main problem is that it requires manual assessment of approximately 50,000 low quality images per examination which is highly time-consuming and labor-intense. / CE analysis and assessment so far treated CE images as individual and independent observations. It is obviously not the case as there is often significant overlap among images. In particular, CE captures multiple views of the same anatomy as the capsule is slowly propelled by peristalsis. Our broader work aims to perform computer aided diagnosis (CAD) in endoscopy using all available information, including multiple images. / In this dissertation, a framework of multi-class Hidden Markov Models (HMM) embedded with statistical classifiers for combining information from multiple CE images is proposed. Due to the low quality of CE image, pre-processing is performed to enhance CE images by increasing the contrast and removing noises. Several image enhancement methods are investigated and customized for CE images. For frame-based supervised classification, AdaBoost is used as the ensemble classifier to combine multiple classifiers, i.e. support vector machine (SVM), k-nearest neighbor (k-NN), and Bayes classifier. Before classification, color, edge and texture features are extracted and fused. Finally, both supervised and unsupervised methods are proposed for CE study synopsis. For supervised method, a flexible and extensible framework based on HMM is developed to integrate temporal information in CE images. It can be extended to multi-class, multi-features, and multi-states. Improvements can be made by combined HMM and Parallel HMM (PHMM) which are introduced as decision-level fusion schemes. Combined HMM considers different sources via a multi-layer HMM model to perform classification and video synopsis. PHMM employs Bayesian inference to combine the recognition results at decision level. For unsupervised method, illumination-independent opponent color moment invariants and local binary pattern (LBP) based on Contourlet transform are explored as color and texture features, respectively. Pair-wise image dissimilarity is measured in the feature space and treated as points on an open contour in a 2-D plane. CE video is segmented based on sudden change points which are detected using a non-parametric key-point detection method. From each segment, representative frames are extracted to summarize the CE video. Validation results on simulated and real patient data show promising performance of the proposed framework. It has great potential to achieve automatic assessment for CE images. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Zhao, Qian. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2012. / Includes bibliographical references (leaves 142-175). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese. / Abstract --- p.ii / Acknowledgments --- p.vii / List of Tables --- p.xiii / List of Figures --- p.xv / Chapter 1 --- The Relevance of Synopsis --- p.1 / Chapter 1.1 --- Problem Statement --- p.1 / Chapter 1.2 --- Application - Capsule Endoscopy Assessment --- p.4 / Chapter 1.3 --- Literature Review --- p.9 / Chapter 1.3.1 --- Methods Based on Frame Classification --- p.11 / Chapter 1.3.2 --- Methods Integrating Temporal Information --- p.14 / Chapter 1.4 --- Contributions --- p.19 / Chapter 1.5 --- Organization --- p.23 / Chapter 2 --- Preliminary --- p.25 / Chapter 2.1 --- Hidden Markov Model (HMM) --- p.25 / Chapter 2.2 --- Factorial HMM --- p.35 / Chapter 3 --- Temporal Integration in Capsule Endoscopy Image Analysis --- p.37 / Chapter 3.1 --- Pre-processing --- p.38 / Chapter 3.2 --- Feature Extraction --- p.43 / Chapter 3.3 --- Frame-based Supervised Classification --- p.47 / Chapter 3.3.1 --- Supervised Classification using Individual Frames --- p.47 / Chapter 3.3.2 --- Ensemble Learning Based on AdaBoost --- p.50 / Chapter 3.4 --- Sequence-based Supervised Classification --- p.52 / Chapter 3.5 --- Experiments --- p.58 / Chapter 3.5.1 --- Capsule Endoscopy Image Enhancement --- p.60 / Chapter 3.5.2 --- Frame-based Supervised Classification --- p.67 / Chapter 3.5.3 --- Image Sequence Classification --- p.68 / Chapter 3.6 --- Discussion --- p.80 / Chapter 3.7 --- Summary --- p.82 / Chapter 4 --- Capsule Endoscopy Study Synopsis --- p.98 / Chapter 4.1 --- Supervised Synopsis Using Statistical Models --- p.98 / Chapter 4.2 --- Unsupervised Synopsis via Representative Frame Extraction --- p.100 / Chapter 4.2.1 --- Feature Extraction --- p.100 / Chapter 4.2.2 --- Non-parametric Key-point Detection --- p.111 / Chapter 4.2.3 --- Representative Frame Extraction --- p.112 / Chapter 4.3 --- Experiments --- p.119 / Chapter 4.3.1 --- Supervised Synopsis Based on HMM --- p.119 / Chapter 4.3.2 --- Unsupervised Synopsis --- p.125 / Chapter 4.4 --- Discussion --- p.132 / Chapter 4.5 --- Summary --- p.133 / Chapter 5 --- Conclusions and Future Work --- p.138 / Chapter 5.1 --- Conclusions --- p.138 / Chapter 5.2 --- Future Work --- p.141 / Bibliography --- p.142

A feature extraction approach based on color is firstly proposed. Exploiting color histogram of an image, we can obtain distribution of different colors in images. Then we employ minimum distance classifier based on a new distance criterion to judge status of regions. In this section, we also validate benefits of WCE image enhancement to the proposed CAD system. / Finally, we propose a new approach of chrominance moment as another kind of feature to discriminate normal regions from abnormal regions, which makes full use of Tchebichef polynomials and HSI color space. This new feature extraction scheme preserves illumination invariance without numerical approximation. / In conclusion, this thesis investigates several major and challenging problems such as WCE images enhancement and feature extractions in CAD for WCE images, and proposes several novel schemes to solve those problems. Extensive experiments are reported to demonstrate effectiveness of the proposed algorithms. / Next, we investigate automatic diseases detection for WCE images to partially solve the second problem. In this part we explore different features that are suitable for detection of diseases from three viewpoints, i.e., color, texture and chromaticity, because clinicians mainly use these clues to diagnose. At the same time, we introduce their corresponding classifiers. / We further advance a new texture feature extraction method, curvelet based local binary pattern, to detect abnormal regions in WCE images. This method takes advantage of curvelet transform and local binary pattern to describe textural features of WCE images. / Wireless capsule endoscopy (WCE) is a state-of-the-art technology to diagnose gastrointestinal (GI) tract diseases without invasiveness. However, there exist two major problems concerning WCE images. One problem is that many images for diagnosis have rather low contrast and are noisy, which causes difficulties to diagnosis and also to computer-aided detection, so it is necessary to enhance these images. The other one is that the viewing process of video data per examination is very time consuming because of the great amount of video data. If we can use computerized methods to help the physicians detect some abnormal regions in WCE images, it will certainly reduce the burden of physicians. Focusing on these two goals, this thesis mainly studies some main challenging problems in computer-aided diagnosis (CAD) system for WCE images. To solve the first problem, we put forward an adaptive curvature strength diffusion method to enhance WCE images. Based on local characteristics analysis of WCE images, we propose a new concept of curvature strength. Then, we employ curvature strength diffusion to enhance WCE images with an adaptive choice of conductance parameter. Finally, we extend the curvature strength diffusion to color space since WCE images are color images. / Li, Baopu. / Adviser: Max Q. H. Meng. / Source: Dissertation Abstracts International, Volume: 70-06, Section: B, page: 3640. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 126-150). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

Among all the major infectious human diseases, gastro-intestinal infections caused by microbial pathogens are a major cause of morbidity and infant death in developing countries, largely due to inadequate sewage disposal and contaminated water. Traditional health practitioners in South Africa play a crucial role in providing health care to the majority of the population. Many plants are locally used by South African traditional healers to treat microbial infections related to gastro-intestinal tracts. Ethnopharmacological and ethnobotanical studies using traditional knowledge as a selection strategy has given priority to certain plants for isolation and identification of plant novel bioactive compounds. Pharmacological and phytochemical studies of the investigated twelve medicinal plant species (from 10 families) extensively used as antimicrobials against gastro-intestinal infections was necessary to validate the use of the plants. Furthermore, to provide sufficient preliminary information for the isolation and identification of active compounds that are present in the investigated plants. Plant parts were sequentially extracted using petroleum ether (PE), dichloromethane (DCM) and 70% ethanol (EtOH). Cold water and boiled (decoction) extracts of the plant materials were prepared non- sequentially. Among the extracts, EtOH yielded the highest amount of plant substances. A total number of 85 extracts were evaluated for antibacterial activity, 80 for antifungal activity, 64 for anti-inflammatory activity, and 27 biologically active extracts were tested for genotoxicity. The microdilution method was used to determine the minimum inhibitory concentration values in the antibacterial assay against two Gram-negative bacteria (Escherichia coli ATCC 11775 and Klebsiella pneumoniae ATCC 13883) and two Gram-positive bacteria (Bacillus subtilis ATCC 6051 and Staphylococcus aureus ATCC 12600). A modified microdilution method was used to determine the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values in the antifungal assay against Candida albicans. Cyclooxygenase assay was used to evaluate the anti-inflammatory activity of the extracts against cyclooxygenase-1 and -2 (COX-1 and COX-2) enzymes. The plant extracts were screened first at a concentration of 250 ƒÊg/ml per test sample, and then further screened at concentrations of 125 and 62.5 ƒÊg/ml for extracts that inhibited the COX-2 enzyme. The Ames test was used to test for genotoxicity in extracts that showed interesting pharmacological activities using Salmonella typhimurium strain TA98. Among the screened extracts, 25 extracts showed good antibacterial activity with MIC values . 1.0 mg/ml. Dichloromethane extracts exhibited the greatest antibacterial activity, and Gram-positive bacteria were most susceptible. The best antibacterial activity was exhibited by Becium obovatum leaf EtOH extracts with an MIC value of 0.074 mg/ml. A broad spectrum antibacterial activity was observed by leaf extracts of Cucumis hirsutus (PE), Haworthia limifolia (PE), Protea simplex (PE and DCM) and Dissotis princeps (EtOH) against both Gram-negative and Gram-positive bacteria. No interesting antibacterial activity was exhibited by water extracts with the exception of Dissotis princeps water extract with a good antibacterial activity against Gram-positive and Gram-negative bacteria. In the antifungal assay, 6 extracts showed interesting antifungal activity. Protea simplex leaf PE extract showed the best fungicidal activity with an MFC value of 0.014 mg/ml. The best overall antifungal activity was observed in plant EtOH extracts. Some extracts from Agapanthus campanulatus (leaves and roots), Dissotis princeps (leaves), Gladiolus dalenii (corms) and Protea simplex (leaves) showed good activity against Candida albicans. Twenty one extracts inhibited the COX-1 enzyme, while fifteen extracts inhibited the COX-2 enzyme at the lowest screening concentration of 62.5 ƒÊg/ml. The highest COX-1 inhibition at a concentration of 62.5 ƒÊg/ml was exhibited by Diospyros lycioides leaf PE extract (89.1%) while Agapanthus campanulatus root DCM extract showed the highest COX-2 inhibitory activity (83.7%) at the same concentration. In the Ames test, no genotoxicity was observed in any of the extracts, however more tests need to be done to confirm these results. Thin layer chromatograms of the organic solvent plant extracts were developed. The fingerprints of the plant extracts showed colours of bands at different Rf values when viewed under UV254 and UV366 suggesting that the investigated plant species contained different compounds in the extracts. In the quest to understand the source of the plants pharmacological activities, total phenolic compounds including condensed tannins, gallotannins and flavonoids were quantitatively investigated in terms of their amounts in the aqueous methanol extracts of the plants materials using spectrophotometric methods. Alkaloids and saponins were qualitatively determined. The amounts of total phenolics were determined by the Folin Ciocalteu assay, condensed tannins were determined by the butanol-HCl assay, while rhodanine and vanillin assays were used to determine the amounts of gallotannins and flavonoids respectively. Dragendorff reagent was used to detect alkaloids in the plant extracts on thin layer chromatographic plates, while the froth test was employed to detect saponins. Secondary metabolites varied with plant parts and species with Cyperus textilis (leaf) having the highest amounts of total phenolics, condensed tannins and flavonoids. The highest amount of gallotannins was detected in Protea simplex leaf extracts. All the investigated plant materials with the exception of Haworthia limifolia leaf, Protea simplex leaf, Antidesma venosum leaf and Dissotis princeps leaf tested positively to saponins. Alkaloids were detected in Haworthia limifolia leaf (PE and EtOH), Cucumis hirsutus leaf (EtOH), Becium obovatum root (DCM), Protea simplex root and bark (EtOH), Agapanthus campanulatus root (DCM) and leaf (EtOH), Cyperus textilis root (DCM), Vernonia natalensis leaf (PE), Antidesma venosum leaf (PE), Diospyros lycioides leaf (PE) and Dissotis princeps leaf (DCM) extracts. The results obtained from the investigation of the pharmacology and phytochemistry of the plant species used to treat microbial infections related to gastro-intestinal tracts, provide sufficient preliminary information to validate the use of some of the plants in traditional medicine. The information provided might be considered sufficient for further studies aimed at isolating and identifying the active compounds in the plant species, and evaluating possible synergism amongst the isolated compounds. / Thesis (M.Sc)-University of KwaZulu-Natal, Pietermaritzburg, 2009.

Made available in DSpace on 2014-06-11T19:25:26Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-04-30Bitstream added on 2014-06-13T20:33:01Z : No. of bitstreams: 1 rozza_al_me_botib.pdf: 637817 bytes, checksum: 8ebe24dd454c0104e96eebe3786bda97 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / O presente trabalho teve como objetivos testar a atividade gastroprotetora de úlceras gástricas e mecanismos de ação do óleo essencial de Croton cajucara (CC), do óleo essencial de Citrus lemon (CL) e dos constituintes majoritários de CL, que são o Limoneno (L) e o β- pineno (P). Assim, foram realizados modelos de indução de úlcera gástrica por etanol absoluto para CL, L, P e CC e por droga anti-inflamatória não esteroidal (Indometacina) para CL, L e P. Todos os resultados foram expressos em média  epm (p<0.05). No modelo de indução de úlceras por etanol absoluto, a área das lesões (mm2) foi 0.00  0.00** para CL, L e CC (100% de gastroproteção), 73.20  27.32 para P, que não exerceu efetiva gastroproteção (53.26%), 22.27  8.21** para o controle positivo (85.80%) e 156.60  36.30 para o veículo. O escore microscópico indicou excelente preservação da mucosa por CL**, L*** e CC***. A área de marcação imunoistoquímica para heat shock protein 70 foi estatisticamente maior nos grupos CL, L, P e CC e para peptídeo intestinal vasoativo foi maior nos grupos CL, L e P. Os níveis de glutationa (GSH, em μg/ml) foram 1182.00  52.47** para CL, 1316.6  67.75** para L, 1286.5  93.15* para CC, 1195.60  37.57** para o controle positivo, 982.8  79.07** para o veículo e 1704.30 ± 149.03 para o grupo branco. Na indução de úlcera por Indometacina, CL exerceu gastroproteção de 98.3% com área de lesão (mm2) 0.85 ± 0.85**, L exerceu gastroproteção de 50.1% (área lesada 24.34 ± 5.3**), P não exerceu efetivo efeito gastroprotetor (37%) com área lesada 30.66 ± 4.22, contra 66.6% de gastroproteção e 16.27 ± 4.49** para o controle positivo e 48.72 ± 6.64 de área lesada para o veículo. CL administrado isoladamente manteve os níveis gástricos de PGE2 (em ng/ml) em 18,25 ± 2,58, mesmo com a administração em conjunto com... / This study aimed to test the gastroprotective activity and the mechanism of action of the essential oil of Croton cajucara (CC), the essential oil of Citrus lemon (CL) and the majoritary substances present in CL, wich are Limonene (L) and β-pinene (P). Then, gastric ulcers in rats were induced by absolute ethanol after oral treatment with CL, L, P and CC and by indometacin (non-steroidal anti-inflamatory drug) after oral treatment with CL, L and P. All results were expressed in mean  standard error mean (p<0.05). In ethanol-induced gastric ulcer, the ulcer area (mm²) were 0.00  0.00** for CL, L and CC (100% of gastroprotection), 73.20  27.32 for P (53.26% of the ulcer area was reduced, however there was no effective gastroprotection), 22.27  8.21** for the positive control (85.80%) and 165.60  36.30 for the vehicle. The microscopic score showed gastric mucosa was preserved in CL**, L*** and CC***. The marked area for heat shock protein 70 (HSP-70) and vasoactive intestinal peptide (VIP) immunohistochemistries were statistically augmented in CL, L and P groups. The levels of glutathione (GSH, μg/ml) were 1182.00  52.47** for CL, 1316.6  67.75** for L, 1286.5  93.15* for CC, 1195.60  37.57** for the positive control, 982.8  79.07** for the vehicle and 1704.30 ± 149.03 for the sham group. In the indomethacin-induced gastric ulcer, CL offered 98.3% gastroprotection (ulcer area 0.85 ± 0.85**), L offered 50.1% gastroprotection (ulcer area 24.34 ± 5.3**), P did not show gastroprotective effect (37%) and presented ulcer area 30.66 ± 4.22. The positive control offered 66.6% gastroprotection (ulcer area 16.27 ± 4.49**) and the vehicle presented ulcer area 48.72 ± 6.64. CL was able to maintain the PGE2 levels (ng/ml) 18.25 ± 2.58 near to sham group (21.14 ± 1.14), even with indomethacin (PGE2 inhibitor) administration (17.89 ± 1.55), compared with ... (Complete abstract click electronic access below)

Resumo: O presente trabalho teve como objetivos testar a atividade gastroprotetora de úlceras gástricas e mecanismos de ação do óleo essencial de Croton cajucara (CC), do óleo essencial de Citrus lemon (CL) e dos constituintes majoritários de CL, que são o Limoneno (L) e o β- pineno (P). Assim, foram realizados modelos de indução de úlcera gástrica por etanol absoluto para CL, L, P e CC e por droga anti-inflamatória não esteroidal (Indometacina) para CL, L e P. Todos os resultados foram expressos em média  epm (p<0.05). No modelo de indução de úlceras por etanol absoluto, a área das lesões (mm2) foi 0.00  0.00** para CL, L e CC (100% de gastroproteção), 73.20  27.32 para P, que não exerceu efetiva gastroproteção (53.26%), 22.27  8.21** para o controle positivo (85.80%) e 156.60  36.30 para o veículo. O escore microscópico indicou excelente preservação da mucosa por CL**, L*** e CC***. A área de marcação imunoistoquímica para heat shock protein 70 foi estatisticamente maior nos grupos CL, L, P e CC e para peptídeo intestinal vasoativo foi maior nos grupos CL, L e P. Os níveis de glutationa (GSH, em μg/ml) foram 1182.00  52.47** para CL, 1316.6  67.75** para L, 1286.5  93.15* para CC, 1195.60  37.57** para o controle positivo, 982.8  79.07** para o veículo e 1704.30 ± 149.03 para o grupo branco. Na indução de úlcera por Indometacina, CL exerceu gastroproteção de 98.3% com área de lesão (mm2) 0.85 ± 0.85**, L exerceu gastroproteção de 50.1% (área lesada 24.34 ± 5.3**), P não exerceu efetivo efeito gastroprotetor (37%) com área lesada 30.66 ± 4.22, contra 66.6% de gastroproteção e 16.27 ± 4.49** para o controle positivo e 48.72 ± 6.64 de área lesada para o veículo. CL administrado isoladamente manteve os níveis gástricos de PGE2 (em ng/ml) em 18,25 ± 2,58, mesmo com a administração em conjunto com ... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: This study aimed to test the gastroprotective activity and the mechanism of action of the essential oil of Croton cajucara (CC), the essential oil of Citrus lemon (CL) and the majoritary substances present in CL, wich are Limonene (L) and β-pinene (P). Then, gastric ulcers in rats were induced by absolute ethanol after oral treatment with CL, L, P and CC and by indometacin (non-steroidal anti-inflamatory drug) after oral treatment with CL, L and P. All results were expressed in mean  standard error mean (p<0.05). In ethanol-induced gastric ulcer, the ulcer area (mm²) were 0.00  0.00** for CL, L and CC (100% of gastroprotection), 73.20  27.32 for P (53.26% of the ulcer area was reduced, however there was no effective gastroprotection), 22.27  8.21** for the positive control (85.80%) and 165.60  36.30 for the vehicle. The microscopic score showed gastric mucosa was preserved in CL**, L*** and CC***. The marked area for heat shock protein 70 (HSP-70) and vasoactive intestinal peptide (VIP) immunohistochemistries were statistically augmented in CL, L and P groups. The levels of glutathione (GSH, μg/ml) were 1182.00  52.47** for CL, 1316.6  67.75** for L, 1286.5  93.15* for CC, 1195.60  37.57** for the positive control, 982.8  79.07** for the vehicle and 1704.30 ± 149.03 for the sham group. In the indomethacin-induced gastric ulcer, CL offered 98.3% gastroprotection (ulcer area 0.85 ± 0.85**), L offered 50.1% gastroprotection (ulcer area 24.34 ± 5.3**), P did not show gastroprotective effect (37%) and presented ulcer area 30.66 ± 4.22. The positive control offered 66.6% gastroprotection (ulcer area 16.27 ± 4.49**) and the vehicle presented ulcer area 48.72 ± 6.64. CL was able to maintain the PGE2 levels (ng/ml) 18.25 ± 2.58 near to sham group (21.14 ± 1.14), even with indomethacin (PGE2 inhibitor) administration (17.89 ± 1.55), compared with ... (Complete abstract click electronic access below) / Orientador: Cláudia Helena Pellizon / Coorientador: Clélia Akiko Hiruma-Lima / Banca: Maria de Lourdes Mendes Vicentini Paulino / Banca: Lourdes Campaner dos Santos / Mestre

Le métabolisme des phosphoinositides est constitué d’un réseau complexe d’enzymes et de seconds messagers phospholipidiques et solubles cruciaux pour de nombreux processus cellulaires. Le phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3), second messager très important dans la cellule est contrôlé par plusieurs phosphatases. La phosphatase PTEN, fréquemment mutée dans de nombreux cancers humains (glioblastome, cancer de la prostate, cancer du sein, …), le déphosphoryle en position 3 pour donner du phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Les cellules de mammifères possèdent également une activité « inositol 5-phosphatase » pour de nombreux dérivés du myo-inositol. C’est la protéine SHIP2 (SH2-containing Inositol 5-phosphatase 2), une lipide phosphatase membre de la famille des phosphatidylinositol polyphosphate 5-phosphatases qui est, entre autres, responsable de cette activité. <p>Le but de ce travail de thèse a été de mettre en évidence un rôle potentiel de SHIP2 et/ou PTEN dans un modèle murin de tumeurs stromales gastro-intestinales (GIST) ;ce modèle exprime une forme constitutivement active du récepteur tyrosine kinase Kit muté sur l’acide aminé 641. Les souris qui ont été générées par le groupe du Dr Brian Rubin (Lerner Research Institute and Taussig Cancer Center, Cleveland) sont dénommées, les souris KitK641E.<p>La caractérisation des souris KitK641E nous a permis de montrer que SHIP2 et PTEN étaient exprimés dans les cellules Kit positives, les cellules de Cajal et qu’ils semblaient régulés de façons différentes.<p>En effet, nous avons pu mettre en évidence une augmentation de l’expression de PTEN dans l’antre gastrique des souris KitK641E homozygotes. Cette augmentation d’expression a également été observée dans l’antre gastrique de souris double transgéniques KitK641E x PTEN+/- alors que l’expression de PTEN dans le foie, un tissu n’exprimant pas de cellules Kit positives, était bien diminuée. Des expériences de PCR quantitative ont également permis de montrer que cette augmentation d’expression de PTEN ne provenait pas d’une augmentation du taux d’ARNm mais qu’elle se situait plutôt au niveau post-traductionnel. Ces données nous permettent de conclure que l’augmentation d’expression de PTEN dans les cellules Kit positives des souris KitK641E homozygotes est influencée par l’activation constitutive du récepteur Kit. <p>A l’inverse, l’expression de SHIP2 dans les cellules Kit positives n’a pu être mise en évidence qu’après activation constitutive du récepteur Kit. En parallèle, l’étude des voies de signalisation dépendantes du récepteur Kit nous ont permis de montrer que la phosphorylation de PKB ne semblait pas être affectée et que ce serait plutôt la voie des MAPK kinases qui interviendrait dans ce modèle. <p>Nous avons également observé la localisation subcellulaire de SHIP2 et de PTEN en utilisant un modèle cellulaire de cellules GIST882 (cellules dérivées d’un GIST humain portant la mutation correspondante à notre modèle murin). Dans ce modèle, PTEN est principalement localisé dans le noyau alors que SHIP2 est localisé à la fois au sein du noyau et du cytoplasme. Ce modèle nous a également permis de montrer que la forme phosphorylée sur tyrosine de SHIP2 (Y1135) était localisée dans le noyau et qu’elle était modulée en fonction du cycle cellulaire.<p>En conclusion, ces travaux ont permis de montrer que dans le modèle de souris KitK641E, SHIP2 et PTEN étaient localisés au sein des cellules Kit positives et qu’ils étaient modulés par des mécanismes différents. L’augmentation d’expression de PTEN observée dans les souris KitK641E homozygotes pourrait constituer un mécanisme de rétrocontrôle négatif afin de modifier l’impact de voies de signalisation en aval du récepteur Kit dans ce modèle oncogénique.<p> / Doctorat en Sciences biomédicales et pharmaceutiques / info:eu-repo/semantics/nonPublished

Caesalpinia pyramidalis, is an endemic plant from the North east of Brazil which present scientifically proven anti-inflamatory, antinociceptive, and gastroprotective activities. This work aimed at evaluating the gastroprotective effect of the extract of Caesalpinia pyramidalis (EECp) bark in acute gastric ulcers induced by ethanol in Wistar rats. The ulcered animals were treated with a dose of 100mg/kg of EECp and L-NAME (nitric acid blocker) and Propargylglycine (hydrogen sulfide blocker). It was evaluated, in all treatments, the role of the gas mediators such as nitric oxide (NO) and hydrogen sulfide (H2S) and also the participation of mast cells and molecules involved in the anti-inflamatory process as iNOS and citocin IL-4. It was observed in the NO evaluation that the treatment with L-NAME was not able to revert the inhibitory effect of EECp on the ulcers induced by ethanol, showing that the EECp does not operate via NO. However, the H2S can operate in the gastro protection of the EECp as its block hindered the gastroprotective effect on the ulcers induced by ethanol. In order to evaluate the mast cells, histological cuts were made with toluidine blue/alcian blue/safranine where different mast cells phenotypes were observed. In all treatments a prevalence of mucous mast cells was observed. The techniques of immunofluorescence and flow cytometry were used to evaluate IL-4 and iNOS. The ulcered animals treated with EECp presented high expression of IL-4 and low expression of iNOS, suggesting an anti-inflammatory activity of EECp. In conclusion, the gastroprotective effect of EECp and its action mechanism are related to H2S in diminishing the oxidative stress, the induced NO synthase, and the positive immunomodulatory effect for IL-4, with the diminution of mucous mast cells during the inflammatory process. / A Caesalpinia pyramidalis, planta endêmica da região do Nordeste é utilizada popularmente para tratamento de diversos distúrbios patológicos e possui ação anti-inflamatória, anti-nociceptiva e gastroprotetora. O objetivo desse trabalho foi avaliar o efeito gastroprotetor do extrato da entrecasca da Caesalpinia pyramidalis (EECp) em modelos de úlcera aguda induzidas por etanol em ratos Wistar. Os animais ulcerados foram tratados com EECp na dose de 100 mg/kg, com L-NAME (bloqueador de óxido nítrico) e Propargilglicina (bloqueador de sulfeto de hidrogênio). Para todos os tratamentos foi avaliado o papel de mediadores gasosos como óxido nítrico (NO) e sulfeto de hidrogênio H2S, e também a participação de mastócitos e de moléculas envolvidas no processo inflamatório como a iNOS e a citocina IL-4. Na avaliação dos de NO observamos que o tratamento com L-NAME não foi capaz de reverter o efeito inibitório da EECp sobre as úlceras induzidas por etanol, demonstrando que o EECp não age pela via do NO. Contudo o H2S pode estar atuando na gastroproteção do EECp pois o seu bloqueio impediu o efeito gastroprotetor sobre as úlceras induzidas por etanol. Para avaliação de mastócitos cortes histológicos foram corados com azul de toluidina/ alcian blue/ safranina onde observamos diferentes fenótipos de mastócitos. Observamos um predomínio de mastócitos mucosos em todos os tratamentos. Para a avaliação de IL-4 e de iNOS foram utilizadas as técnicas de imunofluorescência e citometria de fluxo. Observamos que os animais ulcerados tratados com EECp apresentaram alta expressão de IL-4 e baixa expressão de iNOS, sugerindo uma atividade anti-inflamatória da EECp. Pode-se concluir que o efeito gastroprotetor do EECp e o possível mecanismo de ação, está relacionado ao H2S na diminuição do estresse oxidativo, diminuição do NO sintase induzível e com o efeito imunomodulatório positivo para IL-4, como a diminuição de mastócitos mucosos durante o processo inflamatório.

Ho Toi Sze Joyce. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 65-74). / Abstracts in English and Chinese. / Acknowledgement --- p.ii / Contents --- p.iii / Abstract --- p.viii / List of Abbreviations --- p.xvii / List of Tables --- p.xix / List of Figures --- p.xx / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- The role of Non-steroidal anti-inflammatory drugs (NSAIDs) --- p.1 / Chapter 1.2 --- NSAID-induced gastrointestinal (GI) toxicity --- p.1 / Chapter 1.2.1 --- Pathogenesis of NSAID-induced GI toxicity --- p.2 / Chapter 1.2.2 --- GI symptoms --- p.4 / Chapter 1.2.3 --- GI ulcers --- p.4 / Chapter 1.2.4 --- GI complications --- p.5 / Chapter 1.2.5 --- Risk factor for GI complications --- p.6 / Chapter 1.2.6 --- Ulcerogenicity of different NSAIDs in upper GI events --- p.6 / Chapter 1.3 --- Prevention of NSAID-induced GI toxicity --- p.7 / Chapter 1.3.1 --- H2-receptor antagonists --- p.8 / Chapter 1.3.2 --- Misoprostol --- p.8 / Chapter 1.3.3 --- Proton Pump Inhibitor (PPI) --- p.9 / Chapter 1.3.4 --- Selective COX-2 Inhibitors --- p.10 / Chapter 1.3.4.1 --- GI safety of selective COX-2 inhibitors --- p.11 / Chapter 1.3.4.1.1 --- Gastrointestinal outcomes research of rofecoxib --- p.13 / Chapter 1.3.4.1.2 --- Celecoxib Long term Arthritis Safety Study --- p.14 / Chapter 1.3.4.2 --- Cardiovascular toxicity of NSAIDs --- p.15 / Chapter 1.3.4.2.1 --- Cardiovascular toxicity of non-selective NSAIDs --- p.15 / Chapter 1.3.4.2.2 --- Cardiovascular toxicity of selective COX-2 inhibitors --- p.16 / Chapter 1.4 --- Guidelines on the management of osteoarthritis (OA) and rheumatoid arthritis (RA) --- p.21 / Chapter 1.4.1 --- American College of Rheumatology (ACR) Subcommittee --- p.22 / Chapter 1.4.2 --- National Institute for Clinical Excellence (NICE) --- p.23 / Chapter 1.4.3 --- Hong Kong Hospital Authority (HA) --- p.23 / Chapter 1.5 --- Cost of illness of upper GI events in the setting of an emergency room of a regional hospital in Hong Kong and cost analysis of selective COX-2 inhibitor with non-selective NSAID plus gastroprotective agent --- p.24 / Chapter 1.6 --- Objectives --- p.25 / Chapter Chapter 2 --- Cost of illness of upper GI events in the setting of an emergency room of a regional hospital in Hong Kong --- p.26 / Chapter 2.1 --- Methods --- p.28 / Chapter 2.1.1 --- Study site --- p.28 / Chapter 2.1.2 --- Cohort participants --- p.28 / Chapter 2.1.3 --- Resource data collection --- p.29 / Chapter 2.1.4 --- Cost data --- p.30 / Chapter 2.1.5 --- Statistical Methods --- p.31 / Chapter 2.1.6 --- Study perspective --- p.31 / Chapter 2.2 --- Results --- p.31 / Chapter 2.2.1 --- Demographic data --- p.31 / Chapter 2.2.2 --- Total direct medical cost of upper GI complaints in UCH --- p.33 / Chapter 2.3 --- Discussion --- p.35 / Chapter 2.3.1 --- Total direct medical cost of upper GI events --- p.35 / Chapter 2.3.2 --- Cost of upper GI events associated with NSAID usage --- p.38 / Chapter 2.3.3 --- Low dose aspirin on NSAID-induced GI toxicity --- p.38 / Chapter 2.3.4 --- Limitation --- p.39 / Chapter 2.3.5 --- Future study --- p.41 / Chapter 2.4 --- Conclusion --- p.41 / Chapter Chapter 3 --- Cost analysis of selective COX-2 inhibitor versus non-selective NSAID with gastroprotective agent --- p.43 / Chapter 3.1 --- Methods --- p.46 / Chapter 3.1.1 --- Local randomized clinical trial --- p.46 / Chapter 3.1.1.1 --- Study population --- p.46 / Chapter 3.1.1.2 --- Cost data --- p.47 / Chapter 3.1.1.3 --- Statistical Methods --- p.48 / Chapter 3.1.1.4 --- Sensitivity analysis --- p.49 / Chapter 3.1.2 --- Large randomized clinical trial --- p.49 / Chapter 3.1.2.1 --- Study population --- p.49 / Chapter 3.1.2.2 --- Cost data --- p.50 / Chapter 3.2 --- Results --- p.50 / Chapter 3.2.1 --- Local randomized clinical trial --- p.51 / Chapter 3.2.1.1 --- Demographic data --- p.51 / Chapter 3.2.1.2 --- Cost analysis --- p.52 / Chapter 3.2.1.3 --- Sensitivity analysis --- p.53 / Chapter 3.2.2 --- Large randomized clinical trial --- p.54 / Chapter 3.2.2.1 --- Demographic data --- p.54 / Chapter 3.2.2.2 --- Cost analysis --- p.55 / Chapter 3.3 --- Discussion --- p.55 / Chapter 3.3.1 --- Cost analysis --- p.55 / Chapter 3.3.2 --- Sensitivity analysis --- p.59 / Chapter 3.3.3 --- Low dose aspirin on NSAID-induced GI toxicity --- p.59 / Chapter 3.3.4 --- Limitation --- p.60 / Chapter 3.4 --- Future study --- p.62 / Chapter 3.5 --- Conclusion --- p.62 / Chapter Chapter 4 --- Conclusion --- p.63 / Chapter Chapter 5 --- Reference --- p.65 / Appendix Data collection form --- p.75

蠕動是一種能夠幫助食物通過胃腸道以及促進胃腸道產生能動性的類似波浪的收縮運動。它由一種叫做Cajal (ICC)間質細胞的起搏器細胞產生的慢波所控制。ICCs亦幫助由腸神經系統(ENS)到平滑肌的信息傳導。嚙齒動物和人類實驗表明，老化所導致的ICC細胞數量下降和腸神經退化與排便睏難和便秘有關。通過研究ICC和ENS在正常老化情況下和加速膽碱能神經元喪失的阿爾茲海默症(AD)老鼠模型(Tg2576)中的變化，我們對治療神經退化性疾病也許會有新的認識。本課題的目的在于，研究老化情況下正常老鼠模型及澱粉樣前體蛋白質(APP)過量表達下的AD老鼠模型的胃腸道在形態及功能上的變化。 / 六個月大的Tg2576和同齡野生型對照的全樣載片免疫組化實驗顯示， 十二指腸 (P < 0.05)和迴腸 (P < 0.01)中的腸神經細胞顯著降低，迴腸 (P < 0.001)中的GFAP陽性的腸神經膠質細胞也顯著消失。S100陽性的腸神經膠質細胞在胃竇（胃部中的起搏區域）(P < 0.05), 迴腸 (P < 0.05)和結腸 (P < 0.05)中顯著喪失。這些結果表明，在早期的AD階段，ENS已經出現變質。ICC細胞數量在六個月大的Tg2576和同齡野生型對照的所有腸胃部分並沒有顯著性差異 (P > 0.05)。同時，早期AD階段的基本蠕動節奏也並沒有發生改變。除此之外，結腸和十二指腸的GFAP/S100陽性的腸神經膠質細胞比例並沒有顯著增加，表明在早期AD階段，可能出現了炎症。 / 利用石蠟切片進行β澱粉樣蛋白免疫組化，天狼猩紅溶液化驗和硫代黃素T溶液化驗可以測試不溶的澱粉樣斑塊是否存在。結果指出在六個月大的Tg2576所有腸胃部分都觀察到澱粉樣斑塊聚集而在不同的腸胃部分聚集的程度都有所分別。除了結腸外，六個月大的野生型對照所有腸胃部分都觀察不到澱粉樣斑塊聚集。澱粉樣斑塊形成的增長可能和早期AD階段出現的腸神經細胞和腸神經膠質細胞喪失互相關聯。 / 應用電泳轉移酶標免疫印斑技術，測試六個月大的Tg2576和同齡野生型對照的迴腸和結腸中，膽碱乙酰轉移酶 (ChAT，出自興奮神經元)， 神經元型一氧化氮合酶(nNOS，出自抑制神經元)， 膠質細胞源性神經營養因子 (GDNF， 出自腸神經膠質細胞)和可溶解的β澱粉樣蛋白寡聚體的表達是否改變。和野生型對照相比，Tg2576的nNOS的表達在迴腸 (P < 0.05) 而不是結腸 (P > 0.05) 中顯著增加。而ChAT，GDNF和各β澱粉樣蛋白寡聚體 (十二聚物，九聚物和六聚物)在六個月大的Tg2576和同齡野生型對照之間並沒有顯著改變 (P > 0.05)。綜上結果表明，在早期AD階段，腸胃道中的抑制信號有所增加，但是β澱粉樣蛋白寡聚體可能不是引致腸胃道中的腸神經細胞和腸神經膠質細胞喪失的原因。 / 在腸胃道的組織學和生化實驗之後，我們利用了微電極陣列 (MEA) 系統來量度出自胃竇和迴腸的慢波信號。量度出來的主導頻率(DF)和功率分佈可以成為測量在老化的ICR老鼠和早期AD階段下腸胃道的功能有沒有變化的參數。在硝苯地平存在下，尼古丁顯著地刺激三個月大 (P < 0.05) 和 六個月大 (P < 0.05) 的ICR老鼠中胃竇和迴腸的慢波活動但未能引起十二個月大 (P > 0.05) 的ICR老鼠中的慢波活動，說明神經退化可能在十二個月的年齡開始。附加了河豚毒素的情況下，尼古丁不能再刺激三個年齡組中胃竇和迴腸的慢波活動 (P > 0.05)，由此證明了尼古丁是對腸神經細胞起作用再去激發ICC的活動。六個月大的Tg2576和同齡野生型對照之間的胃竇和迴腸的基准讀數沒有顯著分別 (P > 0.05)。然而，尼古丁顯著地增加野生型對照中胃竇和迴腸的DF和胃電過速範圍 (P < 0.05) 但是不能刺激Tg2576中胃竇和迴腸的電流活動 (P > 0.05)，示意在早期AD階段腸胃道中已經出現了腸神經細胞和/或腸神經膠質細胞喪失。 / 綜上所言，研究結果提出AD老鼠模型有形態學，生物化學和功能上的轉變。本課題提供了在研究神經退化疾病上的基礎，也支持ENS是中樞神經系統早期病變前的關口這個假設。 / Peristalsis is the wave-like contraction that moves food along the gastrointestinal (GI) tract and generates GI motility. Peristalsis is modulated by slow waves that originate from pacemaker cells called interstitial cell of Cajal (ICC). ICCs also modulate and transduce inputs from the enteric nervous system (ENS) to the smooth muscle. Recent studies in rodents and humans demonstrated that a decrease in ICC number and enteric neurodegeneration during ageing is associated with difficult bowel movements and constipation. By studying ICC and the ENS during normal aging and in a mouse model (Tg2576) of Alzheimer’s disease (AD) where cholinergic loss may be exaggerated, we may gain new perspectives on the treatment of degenerative diseases. The aim of the present study therefore, was to investigate the morphological and functional changes of the GI tract of mice during ageing and in an AD mouse model over-expressing amyloid precursor protein (APP) using an isolated tissue approach. / Whole mount immunohistochemistry of 6-month-old Tg2576 mice and their age-matched wild type (WT) controls revealed that there were significant losses of enteric neurons in the duodenum (P < 0.05) and ileum (P < 0.001), and of GFAP-positive enteric glial cells in the ileum (P < 0.001). There was also a loss of S100-positive glial cells in the antrum (pacemaker region in the stomach) (P < 0.05), ileum (P < 0.05) and colon (P < 0.05). These results indicated the alteration of the ENS during the early stages of AD. There were no differences in ICC arears of all GI regions between 6-month-old Tg2576 mice and their age-matched WT controls (P > 0.05), and there was no alteration of basal peristaltic rhythm during the early stages of AD. The non-significant increase of GFAP to S100 enteric glial cell ratio in the duodenum and colon might indicate an ongoing inflammatory process in these two GI regions during the early stages of AD. / The presence of insoluble amyloid plaques was studied using Aβ immunohistochemistry, Sirius red assay and Thioflavin-T assay on paraffin wax sections. The aggregation of amyloid plaques was observed in all the GI regions of 6-month-old Tg2576 mice and the levels of amyloid plaque varied in different regions. No amyloid plaques were found in the GI tract of 6-month-old WT animals excepting the colon. The increase in formation of amyloid plaques might be correlated to the losses of enteric neurons and enteric glial cells during the early stages of AD. / Western blot analysis was performed on frozen sections of tissues from the ileum and colon to investigate whether there were changes in choline acetyltransferase (ChAT, from excitatory neurons), neuronal nitric oxide synthase (nNOS, from inhibitory neurons), glial cell line-derived neurotrophic factor (GDNF, from enteric glia) and soluble Aβ oligomers between 6-month-old Tg2576 mice and WT controls. nNOS expression significantly increased in the ileum (P < 0.05) but not in the colon (P > 0.05) of Tg2576 mice compared with WT controls. There were no differences in the expressions of ChAT, GDNF and Aβ oligomers (docecamer, nonamer and hexamer) in the ileum and colon between Tg2576 mice and WT controls (P > 0.05). These results imply that there is an increase in the inhibitory signal in the GI tract during the early stages of AD but soluble Aβ oligomers might not be the cause of neuronal and glial losses in the GI tract. / Following histological and biochemical studies of different GI regions, slow wave signals from the antrum and ileum were measured using a microelectrode array (MEA) system. The dominant frequencies (DFs) and power distributions were measured and these served as parameters for measuring functional changes in the GI tract during ageing in ICR mice and the early stages of AD. In the presence of nifedipine, nicotine significantly stimulated the slow wave activities in the antrum and ileum of 3-month-old (P < 0.05) and 6-month-old (P < 0.05) ICR mice but failed to trigger the slow wave activities in 12-month-old (P > 0.05) ICR mice, suggesting the neurodegeneration might begin with the age between 6 and 12 months. With the addition of tetrodotoxin, nicotine failed to stimulate the slow wave activities in the antrum and ileum of three age groups (P > 0.05) and it showed that nicotine only acted on enteric neurons to trigger the ICC activities. There were no differences in the antral and ileal baseline recordings between 6-month-old Tg2576 mice and their age-matched WT controls (P > 0.05). However, nicotine significantly increased DFs and tachygastria ranges of the antrum and ileum in WT controls (P < 0.05) but failed to increase electrical activitiy of the antrum and ileum in Tg2576 mice (P > 0.05), thus suggesting a loss of neuronal and/or glial cells in the GI tract during the early stages of AD. / In conclusions, these findings suggest the mouse model for AD has morphological, biochemical and functional changes in the GI tract. The present studies provide a foundation for the investigation of degenerative diseases and support the hypothesis that the ENS may be the gateway for the early pathological changes in the central nervous system. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Hui, Chin Wai. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2012. / Includes bibliographical references (leaves 180-200). / Abstracts also in Chinese. / PUBLICATIONS RELATED TO THE WORK IN THIS THESIS --- p.i / ABSTRACT --- p.ii / 摘要 --- p.iv / ACKNOWLEDGEMENTS --- p.vi / LIST OF ABBREVIATIONS --- p.vii / Chapter CHAPTER 1 --- Introduction --- p.1 / Chapter 1.1 --- General introduction --- p.1 / Chapter 1.2 --- Interstitial cells of Cajal (ICCs) as electrical pacemaker cells in GI tract --- p.1 / Chapter 1.2.1 --- ICC subtypes in GI tract --- p.2 / Chapter 1.3 --- Hypotheses of slow wave generation --- p.4 / Chapter 1.3.1 --- Mechanisms of the NSCC pacemaking hypothesis --- p.5 / Chapter 1.3.2 --- Mechanisms of the alternative hypothesis --- p.6 / Chapter 1.4 --- Involvement of ion channels in slow wave generation of ICC --- p.6 / Chapter 1.4.1 --- Calcium channels --- p.6 / Chapter 1.4.2 --- Sodium channels --- p.7 / Chapter 1.4.3 --- Potassium channels --- p.7 / Chapter 1.4.4 --- Chloride channels --- p.8 / Chapter 1.4.5 --- Non-selective cation channels --- p.8 / Chapter 1.5 --- Distribution of several types of receptors in ICC --- p.11 / Chapter 1.5.1 --- Purinergic receptors --- p.11 / Chapter 1.5.2 --- Muscarinic receptors --- p.11 / Chapter 1.5.3 --- Tachykinin receptors --- p.12 / Chapter 1.5.4 --- Vasoactive intestinal peptide receptors --- p.12 / Chapter 1.5.5 --- Serotonin receptors --- p.13 / Chapter 1.6 --- Introductions and functions of enteric nervous system --- p.15 / Chapter 1.6.1 --- Interaction amongst the central, peripheral and enteric nervous system: brain-gut axis --- p.15 / Chapter 1.6.2 --- Enteric neuronal subtypes in the GI tract --- p.15 / Chapter 1.6.2.1 --- Motor neurons --- p.16 / Chapter 1.6.2.2 --- Interneurons --- p.16 / Chapter 1.6.2.3 --- Intrinsic primary afferent neurons --- p.18 / Chapter 1.6.3 --- Enteric glial cells --- p.18 / Chapter 1.6.3.1 --- Enteric glial subtypes in the GI tract --- p.18 / Chapter 1.6.3.2 --- Communication between enteric neurons and glial cells --- p.19 / Chapter 1.6.3.3 --- Possible functions of enteric glial cells in the GI tract --- p.19 / Chapter 1.6.3.3.1 --- Secretion of neurotrophic factors --- p.20 / Chapter 1.6.3.3.2 --- Secretion of reduced glutathione --- p.20 / Chapter 1.6.3.3.3 --- Secretion of transforming growth factor-beta 1 --- p.21 / Chapter 1.7 --- Interactions amongst ICC, enteric neurons and enteric glial cells --- p.21 / Chapter 1.8 --- Gastrointestinal disorders --- p.22 / Chapter 1.8.1 --- Mechanisms for cell depletion --- p.22 / Chapter 1.8.1.1 --- Autoimmune attack --- p.22 / Chapter 1.8.1.2 --- Hyperglycaemia and diabetes mellitus --- p.24 / Chapter 1.8.1.3 --- Oxidative stress --- p.25 / Chapter 1.8.1.4 --- Ageing --- p.26 / Chapter 1.9 --- Alzheimer’s disease --- p.28 / Chapter 1.9.1 --- Genetics and pathogenesis of Alzheimer’s disease --- p.28 / Chapter 1.9.1.1 --- Aggregation of amyloid beta protein --- p.29 / Chapter 1.9.1.2 --- Genetic factors of AD --- p.29 / Chapter 1.9.1.3 --- Tau hyperphosphorylation and neurofibrillary tangles --- p.31 / Chapter 1.9.2 --- Current treatment for Alzheimer’s disease --- p.33 / Chapter 1.9.2.1 --- Symptomatic treatment --- p.33 / Chapter 1.9.2.2 --- Disease-modifying treatment --- p.34 / Chapter 1.9.2.3 --- Other potential drugs for AD treatment --- p.35 / Chapter 1.9.3 --- Possible animal models for AD investigation --- p.36 / Chapter 1.9.4 --- Possible correlations between Alzheimer’s disease and the enteric nervous system --- p.36 / Chapter 1.10 --- Aim of study --- p.37 / Chapter CHAPTER 2 --- Investigation into the morphologies of enteric nervous system and interstitial cell of Cajal in Tg2576 mice --- p.38 / Chapter 2.1 --- Introduction --- p.38 / Chapter 2.1.1 --- Molecular markers for ICC, ENC, and EGC --- p.38 / Chapter 2.1.2 --- Aims and objectives --- p.39 / Chapter 2.2 --- Materials and methods --- p.41 / Chapter 2.2.1 --- Animals --- p.41 / Chapter 2.2.2 --- Tissue preparation --- p.41 / Chapter 2.2.3 --- Immunohistochemistry --- p.42 / Chapter 2.2.4 --- Image acquisition and analysis --- p.43 / Chapter 2.3 --- Results --- p.44 / Chapter 2.3.1 --- General observations --- p.44 / Chapter 2.3.2 --- Area and pattern of ICCs and the ENS in the stomach --- p.46 / Chapter 2.3.3 --- Area and pattern of ICCs and the ENS in the duodenum --- p.52 / Chapter 2.3.4 --- Area and pattern of ICCs and the ENS in the jejunum --- p.56 / Chapter 2.3.5 --- Area and pattern of ICCs and the ENS in the ileum --- p.60 / Chapter 2.3.6 --- Area and pattern of ICCs and the ENS in the colon --- p.66 / Chapter 2.4 --- Discussion --- p.70 / Chapter 2.4.1 --- Major findings --- p.70 / Chapter 2.4.2 --- Possible alterations of the ENS during AD --- p.70 / Chapter 2.4.3 --- Morphological changes of the ENS in relation to genotype --- p.71 / Chapter 2.4.4 --- Morphological changes of ICCs in relation to genotype --- p.72 / Chapter 2.4.5 --- Morphological changes of the ENS and ICCs in relation to GI regions --- p.72 / Chapter 2.4.6 --- Inflammatory conditions in different GI regions --- p.73 / Chapter 2.5 --- Conclusion --- p.74 / Chapter CHAPTER 3 --- Formation of amyloid plaques in the brain and the GI tract of Tg2576 mice --- p.75 / Chapter 3.1 --- Introduction --- p.75 / Chapter 3.1.1 --- The absence of amyloid plaques in rodents --- p.75 / Chapter 3.1.2 --- Overexpression of human APP in transgenic mice --- p.76 / Chapter 3.1.3 --- Distribution of human APP and Aβ deposition in human and transgenic mice --- p.77 / Chapter 3.1.4 --- Transgene and promoter in Tg2576 mouse --- p.77 / Chapter 3.1.5 --- Methods for Aβ plaque detection --- p.78 / Chapter 3.1.6 --- Aim and objectives --- p.78 / Chapter 3.2 --- Materials and methods --- p.80 / Chapter 3.2.1 --- Animals --- p.80 / Chapter 3.2.2 --- Tissue processing --- p.80 / Chapter 3.2.3 --- Preparation of paraffin wax blocks and slide sections --- p.81 / Chapter 3.2.4 --- Aβ immunohistochemistry --- p.82 / Chapter 3.2.5 --- Sirius red assay --- p.83 / Chapter 3.2.6 --- Thioflavin-T assay --- p.84 / Chapter 3.2.7 --- Image acquisition --- p.84 / Chapter 3.3 --- Results --- p.85 / Chapter 3.3.1 --- Aβ immunohistochemistry --- p.85 / Chapter 3.3.1.1 --- The absence of positive immunoreactivity in the brain --- p.85 / Chapter 3.3.1.2 --- The presence of positive immunoreactivity in the GI tract of Tg2576 mice --- p.85 / Chapter 3.3.2 --- Sirius red assay --- p.92 / Chapter 3.3.2.1 --- The presence of positive immunoreactivity in the brain of Tg2576 mice --- p.92 / Chapter 3.3.2.2 --- Characteristics of Sirius red staining in the GI tract --- p.92 / Chapter 3.3.2.3 --- The presence of positive immunoreactivity in the GI tract of Tg2576 mice --- p.92 / Chapter 3.3.3 --- Thioflavin-T assay --- p.98 / Chapter 3.3.3.1 --- The presence of positive immunoreactivity in the brain of Tg2576 mice --- p.98 / Chapter 3.3.3.2 --- The presence of positive immunoreactivity in the GI tract of Tg2576 mice --- p.98 / Chapter 3.4 --- Discussion --- p.104 / Chapter 3.4.1 --- The presence of a small amount of amyloid plaques in the brain of young Tg2576 mice --- p.104 / Chapter 3.4.2 --- The presence of amyloid plaques in the GI tract --- p.104 / Chapter 3.4.3 --- Plaque formation in relation to genotype --- p.105 / Chapter 3.4.4 --- Possible effects of amyloid plaques in the brain and GI tract --- p.106 / Chapter 3.5 --- Conclusion --- p.108 / Chapter CHAPTER 4 --- Expression of Aβ oligomers, ChAT, nNOS and GDNF in the GI tract of Tg2576 mice --- p.109 / Chapter 4.1 --- Introduction --- p.109 / Chapter 4.1.1 --- Common and peripheral types of ChAT --- p.109 / Chapter 4.1.2 --- Three subtypes of NOS --- p.111 / Chapter 4.1.3 --- Functions of glial cell line-derived neurotrophic factor in the ENS --- p.112 / Chapter 4.1.4 --- Neurotoxicity of soluble Aβ peptides --- p.113 / Chapter 4.1.5 --- Aims and objectives --- p.113 / Chapter 4.2 --- Materials and methods --- p.115 / Chapter 4.2.1 --- Animals --- p.115 / Chapter 4.2.2 --- Preparation of materials --- p.115 / Chapter 4.2.3 --- Sample preparation --- p.117 / Chapter 4.2.4 --- Separating and stacking gels preparation --- p.118 / Chapter 4.2.5 --- Western blot --- p.119 / Chapter 4.2.6 --- Image acquisition and analysis --- p.120 / Chapter 4.3 --- Results --- p.122 / Chapter 4.3.1 --- Increase in nNOS expression in the ileum of Tg2576 mice --- p.122 / Chapter 4.3.2 --- No changes in the expressions of Aβ oligomers, ChAT, nNOS and GDNF in the colon of Tg2576 mice --- p.122 / Chapter 4.4 --- Discussion --- p.127 / Chapter 4.4.1 --- The absence of “cholinergic hypothesis of AD in the GI tract of Tg2576 mice --- p.127 / Chapter 4.4.2 --- Increased expression of nNOS in the ileum of Tg2576 mice --- p.128 / Chapter 4.4.3 --- Neuronal and glial losses may be related to the reduced GDNF expression --- p.129 / Chapter 4.4.4 --- No relationship between the Aβ oligomers and neuronal damages in the GI tract --- p.129 / Chapter 4.5 --- Conclusion --- p.129 / Chapter CHAPTER 5 --- Microelectrode array (MEA) study on slow wave activity in the GI tract --- p.131 / Chapter 5.1 --- Introduction --- p.131 / Chapter 5.1.1 --- Components in peristalsis-controlling unit --- p.131 / Chapter 5.1.2 --- Techniques in evaluating slow wave activity --- p.131 / Chapter 5.1.2.1 --- Patch clamp --- p.132 / Chapter 5.1.2.2 --- Calcium imaging --- p.132 / Chapter 5.1.3 --- Application of microelectrode array in evaluating slow wave activity --- p.134 / Chapter 5.1.4 --- Aims and objectives --- p.136 / Chapter 5.2 --- Methods and materials --- p.137 / Chapter 5.2.1 --- Animals --- p.137 / Chapter 5.2.2 --- Tissue preparation --- p.137 / Chapter 5.2.3 --- Electrical recordings --- p.138 / Chapter 5.2.4 --- Analysis and Statistics --- p.139 / Chapter 5.3 --- Results --- p.142 / Chapter 5.3.1 --- Experiments on ICR mice --- p.142 / Chapter 5.3.1.1 --- Nicotine stimulates the slow wave activity in the antrum in the presence of NIF but not in the presence of NIF and 500 nM TTX --- p.142 / Chapter 5.3.1.2 --- Nicotine stimulates the slow wave activity in the ileum in the presence of NIF but only partially stimulates activity in the presence of NIF and 500 nM TTX --- p.152 / Chapter 5.3.1.3 --- The use of 1 μM TTX completely blocked the nicotine stimulation in the ileum --- p.160 / Chapter 5.3.1.4 --- The dominant frequency of baseline increased in the ileum of 12-month-old ICR but not in the antrum in the presence of NIF --- p.162 / Chapter 5.3.2 --- Experiments on Tg2576 mice and their wild type controls --- p.164 / Chapter 5.3.2.1 --- No differences in both antral and ileal baseline DFs between 6- month-old non-transgenic and Tg2576 mice --- p.164 / Chapter 5.3.2.2 --- Nicotine stimulates slow wave activity in the antrum of 6-month-old wild type controls but not of Tg2576 mice --- p.164 / Chapter 5.3.2.3 --- Nicotine stimulates slow wave activity in the ileum of 6-month-old wild type controls but not of Tg2576 mice --- p.167 / Chapter 5.4 --- Discussion --- p.171 / Chapter 5.4.1 --- Pharmacological effects of nicotine in the GI tract --- p.171 / Chapter 5.4.2 --- Excitatory effects of nicotine in the slow wave activities of the stomach and ileum --- p.172 / Chapter 5.4.3 --- Changes of ICC functions and neuronal activities during ageing --- p.174 / Chapter 5.4.4 --- Enteric neurodegeneration leads to alteration in the ENS function in Tg2576 mice --- p.175 / Chapter 5.4.5 --- Conclusion --- p.176 / Chapter CHAPTER 6 --- Concluding discussion --- p.177 / REFERENCES --- p.180

Indiana University-Purdue University Indianapolis (IUPUI) / The class IV alcohol dehydrogenase (ADH7, µ-ADH, σ-ADH) efficiently metabolizes ethanol and retinol. ADH7 is expressed mainly in the upper gastrointestinal tract with no expression in the liver unlike the other ADHs, and is implicated in various diseases including alcoholism, cancer and fetal alcohol syndrome. Genome wide studies have identified significant associations between ADH7 variants and alcoholism and cancer, but the causative variants have not been identified. Due to its association with two important metabolic pathways and various diseases, this dissertation is focused on studying ADH7 regulation and the effects of variants on this regulation using cell systems that replicate endogenous ADH7 expression. We identified elements regulating ADH7 transcription and observed differences in the effects of variants on gene expression. A7P-G and A7P-A, two promoter haplotypes differing in a single nucleotide at rs2851028, had different transcriptional activities and interacted with variants further upstream. A sequence located 12.5 kb upstream (7P10) can function as an enhancer. These complex interactions indicate that the effects of variants in the ADH7 regulatory elements depend on both sequence and cellular context, and should be considered in interpretation of the association of variants with alcoholism and cancer. The mechanisms governing the tissue-specific expression of ADH7 remain unexplained however. We identified an intergenic region (iA1C), located between ADH7 and ADH1C, having enhancer blocking activity in liver-derived HepG2 cells. This enhancer blocking function was cell- and position- dependent with no activity seen in CP-A esophageal cells. iA1C had a similar effect on the ectopic SV40 enhancer. The CCCTC-binding factor (CTCF) bound iA1C in HepG2 cells but not in CP-A cells. Our results suggest that in liver-derived cells, iA1C blocks the effects of downstream ADH enhancers and thereby contributes to the cell specificity of ADH7 expression. Thus, while genetic factors determine level of ADH7 transcriptional activity, iA1C helps determine the cell specificity of transcription.